Lipocine (LPCN) Stock Price, Quote, News & History | Benzinga

SPY777.70+0.06%QQQ759.05+0.17%BTC/USD83,332.64−2.59%DIA511.15+0.03%GLD376.66+0.21%TLT77.10−0.06%

Lipocine Inc (LPCN) Stock Price, Quote, News & History

LPCNNASDAQ

Trade with Public

Trade with Public

$2.20

0.104.76%

Last update: Oct 7, 7:24 PM

$1.98

-0.12-5.71%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$2.95

Close

$2.20

Volume / Avg.

105.74M / 35.87K

Day Range

$2.07 - $3.15

52 Wk Range

1.81 - 12.37

Market Cap

$16.32M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

39

Short Interest

1.23%

Days to Cover

4.58

Recent Lipocine Inc News

Nasdaq Falls Over 100 Points; US Crude Inventories Decline

U.S. stocks fell Wednesday, led by industrials. Crude inventories dropped unexpectedly, while Penguin Solutions and Lipocine surged; Caribou Biosciences

Avi Kapoor

Canadian Approval Of Lipocine Drug Marks Progress for Oral Testosterone Options In Canada

Canada approves Lipocine’s TLANDO for adult males with testosterone deficiency. Partner Verity Pharma plans a launch by the end of 2026.

Vandana Singh

Dow Tumbles 350 Points; Constellation Brands Earnings Top Views

U.S. stocks fell Wednesday; Dow dropped 350 points. Energy rose, materials slid. Constellation beat estimates; oil gained while gold and silver fell.

Avi Kapoor

What's Going On With Carvana Stock Monday?

BofA downgrades Carvana (CVNA) to Neutral, cutting the price target to $360. Explore the latest analyst insights and technical support levels.

Lekha Gupta

What's Going On With Lipocine Stock On Monday?

Lipocine stock rebounds after a steep drop as LPCN 1154 misses the Phase 3 endpoint, with encouraging subgroup data.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-11.19M

Investing Cash Flow (TTM)

-6.15M

Financing Cash Flow (TTM)

16.27M

Free Cash Flow (TTM)

-11.19M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-1.06M

Analyst Trends and Forecast

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$6.04M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

9.04

PB Ratio (TTM)

0.79

Earnings Yield % (TTM)

-88.52%

Earnings Yield % (FWD)

-64.11%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$2.64

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$4.98M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-